870 related articles for article (PubMed ID: 26768987)
1. Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions.
Brodszki N; Turkiewicz D; Toporski J; Truedsson L; Dykes J
Orphanet J Rare Dis; 2016 Jan; 11():5. PubMed ID: 26768987
[TBL] [Abstract][Full Text] [Related]
2. Low-dose donor memory T-cell infusion after TCR alpha/beta depleted unrelated and haploidentical transplantation: results of a pilot trial.
Maschan M; Blagov S; Shelikhova L; Shekhovtsova Z; Balashov D; Starichkova J; Kurnikova E; Boyakova E; Muzalevskii Y; Kazachenok A; Trakhtman P; Osipova E; Khripkova N; Zhogov V; Novichkova G; Maschan A
Bone Marrow Transplant; 2018 Mar; 53(3):264-273. PubMed ID: 29269793
[TBL] [Abstract][Full Text] [Related]
3. Repeated CD45RA-depleted DLI successfully increases donor chimerism in a patient with beta-thalassemia major after haploidentical stem cell transplant.
Chan WYK; Kwok JSY; Chiang AKS; Chan GCF; Lee PPW; Ha SY; Cheuk DKL
Pediatr Transplant; 2021 Aug; 25(5):e13945. PubMed ID: 33314508
[TBL] [Abstract][Full Text] [Related]
4. CD45RA depletion in HLA-mismatched allogeneic hematopoietic stem cell transplantation for primary combined immunodeficiency: A preliminary study.
Touzot F; Neven B; Dal-Cortivo L; Gabrion A; Moshous D; Cros G; Chomton M; Luby JM; Terniaux B; Magalon J; Picard C; Blanche S; Fischer A; Cavazzana M
J Allergy Clin Immunol; 2015 May; 135(5):1303-9.e1-3. PubMed ID: 25282016
[TBL] [Abstract][Full Text] [Related]
5. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L
Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547
[TBL] [Abstract][Full Text] [Related]
6. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies.
Chen X; Hale GA; Barfield R; Benaim E; Leung WH; Knowles J; Horwitz EM; Woodard P; Kasow K; Yusuf U; Behm FG; Hayden RT; Shurtleff SA; Turner V; Srivastava DK; Handgretinger R
Br J Haematol; 2006 Nov; 135(4):524-32. PubMed ID: 17010105
[TBL] [Abstract][Full Text] [Related]
7. Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia.
Merli P; Algeri M; Galaverna F; Milano GM; Bertaina V; Biagini S; Girolami E; Palumbo G; Sinibaldi M; Becilli M; Leone G; Boccieri E; Grapulin L; Gaspari S; Airoldi I; Strocchio L; Pagliara D; Locatelli F
Front Immunol; 2020; 11():699. PubMed ID: 32477328
[TBL] [Abstract][Full Text] [Related]
8. Haploidentical stem cell transplantation augmented by CD45RA negative lymphocytes provides rapid engraftment and excellent tolerability.
Shook DR; Triplett BM; Eldridge PW; Kang G; Srinivasan A; Leung W
Pediatr Blood Cancer; 2015 Apr; 62(4):666-73. PubMed ID: 25559618
[TBL] [Abstract][Full Text] [Related]
9. CD3
Oved JH; Wang Y; Barrett DM; Levy EM; Huang Y; Monos DS; Grupp SA; Bunin NJ; Olson TS
Biol Blood Marrow Transplant; 2019 Mar; 25(3):549-555. PubMed ID: 30312755
[TBL] [Abstract][Full Text] [Related]
10. Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies.
Triplett BM; Shook DR; Eldridge P; Li Y; Kang G; Dallas M; Hartford C; Srinivasan A; Chan WK; Suwannasaen D; Inaba H; Merchant TE; Pui CH; Leung W
Bone Marrow Transplant; 2015 Jul; 50(7):968-77. PubMed ID: 25665048
[TBL] [Abstract][Full Text] [Related]
11. Selective Depletion of αβ T Cells and B Cells for Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation. A Three-Year Follow-Up of Procedure Efficiency.
Li Pira G; Malaspina D; Girolami E; Biagini S; Cicchetti E; Conflitti G; Broglia M; Ceccarelli S; Lazzaro S; Pagliara D; Meschini A; Bertaina A; Montanari M; Locatelli F
Biol Blood Marrow Transplant; 2016 Nov; 22(11):2056-2064. PubMed ID: 27519279
[TBL] [Abstract][Full Text] [Related]
12. Minimal GVHD following in-vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors.
Barge RM; Osanto S; Marijt WA; Starrenburg CW; Fibbe WE; Nortier JW; Falkenburg JH; Willemze R
Exp Hematol; 2003 Oct; 31(10):865-72. PubMed ID: 14550801
[TBL] [Abstract][Full Text] [Related]
13. TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients.
Kaynar L; Demir K; Turak EE; Öztürk ÇP; Zararsız G; Gönen ZB; Gökahmetoğlu S; Şıvgın S; Eser B; Köker Y; Solmaz M; Ünal A; Çetin M
Hematology; 2017 Apr; 22(3):136-144. PubMed ID: 27724812
[TBL] [Abstract][Full Text] [Related]
14. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantation.
Orti G; Lowdell M; Fielding A; Samuel E; Pang K; Kottaridis P; Morris E; Thomson K; Peggs K; Mackinnon S; Chakraverty R
Transplantation; 2009 Dec; 88(11):1312-8. PubMed ID: 19996931
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion.
Soiffer RJ; Alyea EP; Hochberg E; Wu C; Canning C; Parikh B; Zahrieh D; Webb I; Antin J; Ritz J
Biol Blood Marrow Transplant; 2002; 8(11):625-32. PubMed ID: 12463482
[TBL] [Abstract][Full Text] [Related]
17. Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6/6 HLA matched donors.
Rizzieri DA; Dev P; Long GD; Gasparetto C; Sullivan KM; Horwitz M; Chute J; Chao NJ
Bone Marrow Transplant; 2009 Feb; 43(4):327-33. PubMed ID: 18850014
[TBL] [Abstract][Full Text] [Related]
18. αβ T Cell-Depleted Haploidentical Hematopoietic Stem Cell Transplantation without Antithymocyte Globulin in Children with Chemorefractory Acute Myelogenous Leukemia.
Shelikhova L; Ilushina M; Shekhovtsova Z; Shasheleva D; Khismatullina R; Kurnikova E; Pershin D; Balashov D; Radygina S; Trakhtman P; Kalinina I; Muzalevskii Y; Kazachenok A; Zaharova V; Brilliantova V; Olshanskaya Y; Panferova A; Zerkalenkova E; Baidildina D; Novichkova G; Rumyantsev A; Maschan A; Maschan M
Biol Blood Marrow Transplant; 2019 May; 25(5):e179-e182. PubMed ID: 30677509
[TBL] [Abstract][Full Text] [Related]
19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
20. Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
Waller EK; Giver CR; Rosenthal H; Somani J; Langston AA; Lonial S; Roback JD; Li JM; Hossain MS; Redei I
Blood Cells Mol Dis; 2004; 33(3):233-7. PubMed ID: 15528137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
